Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade

Overview of attention for article published in Cell, April 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

So far, Altmetric has seen 7 Google+ posts from 6 users.

Immunotherapy has been arguably the most exciting advancement in the field of cancer therapy, however... Immunotherapy has been…

Immunotherapy has been arguably the most exciting advancement in the field of cancer therapy, however... Immunotherapy has been…

Immunotherapy has been arguably the most exciting advancement in the field of cancer therapy, however... Immunotherapy has been…

Immunotherapy has been arguably the most exciting advancement in the field of cancer therapy, however... Immunotherapy has been…

This page shows the most recent Google+ posts that mention this research output.

Click here to find out how to access more activity, including 3 additional Google+ posts.